Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Blue Sky Uranium Expands Drill Plan to Advance the Ivana Uranium-Vanadium Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
IMAC Holdings Inc
BACK
Healthcare
Medical Care
IMAC Holdings, Inc. provides services related to proteomic products that identify and support oncology clinical treatment decisions and biopharmaceutical drug development. The Company, through its subsidiary, Ignite Proteomics LLC (Ignite Proteomics), leverages its multi-analyte proteomic assay to help oncologists pinpoint the effective targeted therapies for each patient. Its product is a...
patented Reverse Phase Protein Array (RPPA) technology platform, which can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. Ignite Proteomics operates a CLIA-certified and CAP-accredited laboratory and offers single-gene tests by evaluating entire protein pathways in cancer cells. Its commercially available lab developed test (LDT), the Ignite RPPA Assay for Breast Cancer, is being utilized by oncologists across the United States to assist in making the targeted treatment plan for their patients with advanced breast cancer.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCQB:BACK)
New Post
View:
Posts & Comments
Threaded Posts
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 03, 2024 3:51pm
IMAC Holdings, Inc. (NASDAQ:BACK): Navigating the Challenges
https://beyondspx.com/2024/08/02/imac-holdings-inc-nasdaqback-navigating-the-challenges-of-a-shifting-healthcare-landscape/
(105)
•••
Iseneschal
X
Comment by
Iseneschal
on Mar 22, 2024 10:49am
RE:BACK....1st scalp of the day
LoL....in Hindsight.....I sold too early....again Cheers !
(105)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 22, 2024 10:26am
BACK....1st scalp of the day
in and out in 10 mins....LoL Thank for the dough
(105)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 01, 2023 2:20pm
BACK ....crucial pivot point here at ~$2.25
Ideally would like to see a vol spike and respective Price action Never know....but vols have to increase
(105)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 01, 2023 1:30pm
BACK ...geting some "love"
albeit low volume Anything can happen
(105)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 27, 2023 3:10pm
BACK ....don't turn your back on BACK ; )
moving ever so slowly
(105)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 22, 2023 11:57am
BACK ....The old IMAC post RS
On watch at $1.80
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This company is set to benefit from a change in Ontario legislation
How Web3 Will Fundamentally Reshape Finance
Largest integrated facility services provider in Canada releases financial results for Q1, 2025
Healthcare and Clinical Stage Drug Development Company Acquires NoBrainer Imaging Centers